CLINICAL TRIALS PROFILE FOR READYPREP CHG
✉ Email this page to a colleague
All Clinical Trials for READYPREP CHG
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03331263 ↗ | Single Dose CHG Pharmacokinetic Study | Completed | Medline Industries | Phase 1 | 2017-07-21 | A single 2% topical application of ReadyPrep® CHG was applied on either the abdomen (Treatment-1) or the groin (Treatment-2) whereas Treatment-3 consisted of a control treatment where the same procedure as Treatment-1 and -2 was performed, but without the topical application of ReadyPrep® CHG. The treatments were separated by a wash-out of 7 calendar days. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for READYPREP CHG
Condition Name
Clinical Trial Locations for READYPREP CHG
Trials by Country
Clinical Trial Progress for READYPREP CHG
Clinical Trial Phase
Clinical Trial Sponsors for READYPREP CHG
Sponsor Name